Other languages Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
42.47 ^USD	+0.95%		+0.62%	+0.17%

04-18	Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	MT
04-18	Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study	04-18
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson?s Disease	04-18
Actinogen Medical Notifies of Errors on M&A Slide in Recent Presentation	03-25
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,057,890, According to a Recent SEC Filing	03-04
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-27
Sector Update: Health Care Stocks Gain Late Afternoon	02-22
AbbVie Plans $13 Billion Bond Sale to Fund Acquisitions	02-22
AbbVie eyes selling at least $13 bln of bonds to fund M&A, Bloomberg reports	02-21
AbbVie CEO to Retire; COO Robert Michael Named Successor	02-20
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	02-13
AbbVie Completes $10.1 Billion Acquisition of ImmunoGen, Lowers Q1 Adjusted EPS Guidance	02-12
Omzetdaling Abbvie valt mee	02-02
AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals	02-02
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer	01-22
Cerevel Therapeutics Holdings Insider Sold Shares Worth $424,700, According to a Recent SEC Filing	12-28
Cerevel Therapeutics Holdings Insider Sold Shares Worth $331,608, According to a Recent SEC Filing	12-27
Cerevel Therapeutics Holdings Insider Sold Shares Worth $571,972, According to a Recent SEC Filing	12-22
Cerevel Therapeutics Holdings Insider Sold Shares Worth $259,144, According to a Recent SEC Filing	12-22
Cerevel Therapeutics Holdings Insider Sold Shares Worth $292,945, According to a Recent SEC Filing	12-22
Cerevel Therapeutics Holdings Insider Sold Shares Worth $326,788, According to a Recent SEC Filing	12-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Other languages

Filters